197 related articles for article (PubMed ID: 26729896)
1. Increased DNA methylation of Dnmt3b targets impairs leukemogenesis.
Schulze I; Rohde C; Scheller-Wendorff M; Bäumer N; Krause A; Herbst F; Riemke P; Hebestreit K; Tschanter P; Lin Q; Linhart H; Godley LA; Glimm H; Dugas M; Wagner W; Berdel WE; Rosenbauer F; Müller-Tidow C
Blood; 2016 Mar; 127(12):1575-86. PubMed ID: 26729896
[TBL] [Abstract][Full Text] [Related]
2. Ectopic DNMT3B expression delays leukemogenesis.
Stanley RF; Steidl U
Blood; 2016 Mar; 127(12):1525-6. PubMed ID: 27013212
[TBL] [Abstract][Full Text] [Related]
3. Loss of Dnmt3b accelerates MLL-AF9 leukemia progression.
Zheng Y; Zhang H; Wang Y; Li X; Lu P; Dong F; Pang Y; Ma S; Cheng H; Hao S; Tang F; Yuan W; Zhang X; Cheng T
Leukemia; 2016 Dec; 30(12):2373-2384. PubMed ID: 27133822
[TBL] [Abstract][Full Text] [Related]
4. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
[TBL] [Abstract][Full Text] [Related]
5. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.
Bi L; Zhou B; Li H; He L; Wang C; Wang Z; Zhu L; Chen M; Gao S
BMC Cancer; 2018 Feb; 18(1):182. PubMed ID: 29439669
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.
Garzon R; Liu S; Fabbri M; Liu Z; Heaphy CE; Callegari E; Schwind S; Pang J; Yu J; Muthusamy N; Havelange V; Volinia S; Blum W; Rush LJ; Perrotti D; Andreeff M; Bloomfield CD; Byrd JC; Chan K; Wu LC; Croce CM; Marcucci G
Blood; 2009 Jun; 113(25):6411-8. PubMed ID: 19211935
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia.
Niederwieser C; Kohlschmidt J; Volinia S; Whitman SP; Metzeler KH; Eisfeld AK; Maharry K; Yan P; Frankhouser D; Becker H; Schwind S; Carroll AJ; Nicolet D; Mendler JH; Curfman JP; Wu YZ; Baer MR; Powell BL; Kolitz JE; Moore JO; Carter TH; Bundschuh R; Larson RA; Stone RM; Mrózek K; Marcucci G; Bloomfield CD
Leukemia; 2015 Mar; 29(3):567-75. PubMed ID: 25204569
[TBL] [Abstract][Full Text] [Related]
8. Cooperation of Dnmt3a R878H with Nras G12D promotes leukemogenesis in knock-in mice: a pilot study.
Shi X; Yang Y; Shang S; Wu S; Zhang W; Peng L; Huang T; Zhang R; Ren R; Mi J; Wang Y
BMC Cancer; 2019 Nov; 19(1):1072. PubMed ID: 31703632
[TBL] [Abstract][Full Text] [Related]
9. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.
Okano M; Bell DW; Haber DA; Li E
Cell; 1999 Oct; 99(3):247-57. PubMed ID: 10555141
[TBL] [Abstract][Full Text] [Related]
10. Expression of myeloperoxidase in acute myeloid leukemia blasts mirrors the distinct DNA methylation pattern involving the downregulation of DNA methyltransferase DNMT3B.
Itonaga H; Imanishi D; Wong YF; Sato S; Ando K; Sawayama Y; Sasaki D; Tsuruda K; Hasegawa H; Imaizumi Y; Taguchi J; Tsushima H; Yoshida S; Fukushima T; Hata T; Moriuchi Y; Yanagihara K; Miyazaki Y
Leukemia; 2014 Jul; 28(7):1459-66. PubMed ID: 24457336
[TBL] [Abstract][Full Text] [Related]
11. Regulation of DNA methylation and tumor suppression gene expression by miR-29b in leukemia patients and related mechanisms.
Chen YL; Zhang ZX; Shou LH; Di JY
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):158-165. PubMed ID: 29364483
[TBL] [Abstract][Full Text] [Related]
12. DNMT3A in Leukemia.
Brunetti L; Gundry MC; Goodell MA
Cold Spring Harb Perspect Med; 2017 Feb; 7(2):. PubMed ID: 28003281
[TBL] [Abstract][Full Text] [Related]
13. Methyltransferase DNMT3B in leukemia.
Zhang H; Ying H; Wang X
Leuk Lymphoma; 2020 Feb; 61(2):263-273. PubMed ID: 31547729
[TBL] [Abstract][Full Text] [Related]
14. The acute myeloid leukemia variant DNMT3A Arg882His is a DNMT3B-like enzyme.
Norvil AB; AlAbdi L; Liu B; Tu YH; Forstoffer NE; Michie AR; Chen T; Gowher H
Nucleic Acids Res; 2020 Apr; 48(7):3761-3775. PubMed ID: 32123902
[TBL] [Abstract][Full Text] [Related]
15. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis.
Yang L; Liu L; Gao H; Pinnamaneni JP; Sanagasetti D; Singh VP; Wang K; Mathison M; Zhang Q; Chen F; Mo Q; Rosengart T; Yang J
J Hematol Oncol; 2017 Oct; 10(1):159. PubMed ID: 28974232
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of DNMT3b contributes to HOTAIRM1 silencing via DNA hypermethylation in cells transformed by long-term exposure to hydroquinone and workers exposed to benzene.
Zhang H; Yuan Q; Pan Z; Ling X; Tan Q; Wu M; Zheng D; Xie P; Xie D; Liu L
Toxicol Lett; 2020 Apr; 322():12-19. PubMed ID: 31899212
[TBL] [Abstract][Full Text] [Related]
17. Decreases in different Dnmt3b activities drive distinct development of hematologic malignancies in mice.
Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Haney SL; Opavsky R
J Biol Chem; 2021; 296():100285. PubMed ID: 33450231
[TBL] [Abstract][Full Text] [Related]
18. CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.
Spencer DH; Russler-Germain DA; Ketkar S; Helton NM; Lamprecht TL; Fulton RS; Fronick CC; O'Laughlin M; Heath SE; Shinawi M; Westervelt P; Payton JE; Wartman LD; Welch JS; Wilson RK; Walter MJ; Link DC; DiPersio JF; Ley TJ
Cell; 2017 Feb; 168(5):801-816.e13. PubMed ID: 28215704
[TBL] [Abstract][Full Text] [Related]
19. IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation.
Park SM; Cho H; Thornton AM; Barlowe TS; Chou T; Chhangawala S; Fairchild L; Taggart J; Chow A; Schurer A; Gruet A; Witkin MD; Kim JH; Shevach EM; Krivtsov A; Armstrong SA; Leslie C; Kharas MG
Cell Stem Cell; 2019 Jan; 24(1):153-165.e7. PubMed ID: 30472158
[TBL] [Abstract][Full Text] [Related]
20. Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling.
Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Opavsky R
EBioMedicine; 2021 Jan; 63():103191. PubMed ID: 33418509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
